Ethical Considerations in Studying Drug Safety - The Institute of Medicine Report

被引：14

作者：

Mello, Michelle M. ^{[1
]}

Goodman, Steven N. ^{[2
,3
]}

Faden, Ruth R. ^{[4
]}

机构：

[1] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA

[2] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA

[3] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA

[4] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 367卷 / 10期

关键词：

CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; RISK; ROSIGLITAZONE; DEATH; PIOGLITAZONE; NESIRITIDE;

D O I：

10.1056/NEJMhle1207160

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：959 / 964

页数：6

共 30 条

[1] Baucus M, 2010, PREFECT POLICE F PEC
[2] Bioethics and Post-approval Research in Translational Science
Chen, Jiin-Yu
Carter, Michele
[J]. AMERICAN JOURNAL OF BIOETHICS, 2010, 10 (08) : 35 - 37
[3] Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs Institute of Medicine, 2010, ETH ISS STUD SAF APP
[4] Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs Institute of Medicine, 2012, ETH SCI ISS STUD SAF
[5] Committee on the Assessment of the U.S. Drug Safety System Institute of Medicine, 2007, FUT DRUG SAF PROM PR
[6] Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8
Curfman, GD
Morrissey, S
Drazen, JM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (26) : 2813 - 2814
[7] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
Dormandy, JA
Charbonnel, B
Eckland, DJA
Erdmann, E
Massi-Benedetti, M
Kmoules, IK
Skene, AM
Tan, MH
Lefébvre, PJ
Murray, GD
Standl, E
Wilcox, RG
Wlhelmsen, L
Betteridge, J
Birkeland, K
Golay, A
Heine, RJ
Korányi, L
Laakso, M
Mokán, M
Norkus, A
Pirags, V
Podar, T
Scheen, A
Scherbaum, W
Schernthaner, G
Schmitz, O
Skrha, J
Smith, U
Taton, J
[J]. LANCET, 2005, 366 (9493) : 1279 - 1289
[8] The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience
Doshi, Peter
Jefferson, Tom
Del Mar, Chris
[J]. PLOS MEDICINE, 2012, 9 (04)
[9] Food and Drug Administration Center for Drug Evaluation and Research, 2010, JOINT M END MET DRUG
[10] Graham D, 2008, PREFECT POLICE F PEC

← 1 2 3 →